Palisadebio
1 known investors
Palisade Bio is a clinical-stage biopharmaceutical company developing therapies for autoimmune and inflammatory diseases, including its lead candidate PALI-2108, based on a PDE4 prodrug platform.
1 known investors
Palisade Bio is a clinical-stage biopharmaceutical company developing therapies for autoimmune and inflammatory diseases, including its lead candidate PALI-2108, based on a PDE4 prodrug platform.